Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia

Aaron Mansfield, Kari G. Rabe, Susan L Slager, Susan M. Schwager, Timothy G. Call, Jerry D. Brewer, Tait D. Shanafelt

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: Assess compliance with skin cancer screening guidelines in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia (CLL) and evaluate the clinical utility of such screening. Methods: We identified patients diagnosed at Mayo Clinic with CLL between January 1, 2004, and June 1, 2012, who resided within 30 miles of Mayo Clinic. We evaluated adherence to skin cancer screening and identified the prevalence of skin malignancies during follow-up. Medical records were reviewed to document skin cancer screening and diagnosis of a skin malignancy. Results: Collectively, 113 individuals who met criteria were diagnosed with CLL during the study interval. Forty-one patients (36%) had a whole body skin examination by either a dermatologist or primary care provider documented within 6 months of diagnosis; of these; nine (8% of overall cohort; 22% of examined patients) had a skin malignancy identified. Fifteen additional skin malignancies were diagnosed during follow-up. There were a total of 24 skin malignancies (21% of cohort) diagnosed, including basal cell carcinoma (n = 10), squamous cell carcinoma (n = 11), sebaceous carcinomas (n = 2), and melanoma (n = 1). Conclusion: We documented a low compliance with guidelines to screen for skin malignancy in a community-dwelling cohort of patients with newly diagnosed CLL. Standardized and systems-based approaches are likely to increase compliance with skin cancer screening guidelines in patients with CLL.

Original languageEnglish (US)
JournalJournal of Oncology Practice
Volume10
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Independent Living
Skin Neoplasms
B-Cell Chronic Lymphocytic Leukemia
Skin
Early Detection of Cancer
Neoplasms
Guidelines
Basal Cell Carcinoma
Medical Records
Squamous Cell Carcinoma
Melanoma
Primary Health Care
Carcinoma

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy
  • Medicine(all)

Cite this

Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia. / Mansfield, Aaron; Rabe, Kari G.; Slager, Susan L; Schwager, Susan M.; Call, Timothy G.; Brewer, Jerry D.; Shanafelt, Tait D.

In: Journal of Oncology Practice, Vol. 10, No. 1, 2014.

Research output: Contribution to journalArticle

@article{a86442986b4a48bc952050098dd37d25,
title = "Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia",
abstract = "Purpose: Assess compliance with skin cancer screening guidelines in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia (CLL) and evaluate the clinical utility of such screening. Methods: We identified patients diagnosed at Mayo Clinic with CLL between January 1, 2004, and June 1, 2012, who resided within 30 miles of Mayo Clinic. We evaluated adherence to skin cancer screening and identified the prevalence of skin malignancies during follow-up. Medical records were reviewed to document skin cancer screening and diagnosis of a skin malignancy. Results: Collectively, 113 individuals who met criteria were diagnosed with CLL during the study interval. Forty-one patients (36{\%}) had a whole body skin examination by either a dermatologist or primary care provider documented within 6 months of diagnosis; of these; nine (8{\%} of overall cohort; 22{\%} of examined patients) had a skin malignancy identified. Fifteen additional skin malignancies were diagnosed during follow-up. There were a total of 24 skin malignancies (21{\%} of cohort) diagnosed, including basal cell carcinoma (n = 10), squamous cell carcinoma (n = 11), sebaceous carcinomas (n = 2), and melanoma (n = 1). Conclusion: We documented a low compliance with guidelines to screen for skin malignancy in a community-dwelling cohort of patients with newly diagnosed CLL. Standardized and systems-based approaches are likely to increase compliance with skin cancer screening guidelines in patients with CLL.",
author = "Aaron Mansfield and Rabe, {Kari G.} and Slager, {Susan L} and Schwager, {Susan M.} and Call, {Timothy G.} and Brewer, {Jerry D.} and Shanafelt, {Tait D.}",
year = "2014",
doi = "10.1200/JOP.2013.000921",
language = "English (US)",
volume = "10",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "1",

}

TY - JOUR

T1 - Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia

AU - Mansfield, Aaron

AU - Rabe, Kari G.

AU - Slager, Susan L

AU - Schwager, Susan M.

AU - Call, Timothy G.

AU - Brewer, Jerry D.

AU - Shanafelt, Tait D.

PY - 2014

Y1 - 2014

N2 - Purpose: Assess compliance with skin cancer screening guidelines in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia (CLL) and evaluate the clinical utility of such screening. Methods: We identified patients diagnosed at Mayo Clinic with CLL between January 1, 2004, and June 1, 2012, who resided within 30 miles of Mayo Clinic. We evaluated adherence to skin cancer screening and identified the prevalence of skin malignancies during follow-up. Medical records were reviewed to document skin cancer screening and diagnosis of a skin malignancy. Results: Collectively, 113 individuals who met criteria were diagnosed with CLL during the study interval. Forty-one patients (36%) had a whole body skin examination by either a dermatologist or primary care provider documented within 6 months of diagnosis; of these; nine (8% of overall cohort; 22% of examined patients) had a skin malignancy identified. Fifteen additional skin malignancies were diagnosed during follow-up. There were a total of 24 skin malignancies (21% of cohort) diagnosed, including basal cell carcinoma (n = 10), squamous cell carcinoma (n = 11), sebaceous carcinomas (n = 2), and melanoma (n = 1). Conclusion: We documented a low compliance with guidelines to screen for skin malignancy in a community-dwelling cohort of patients with newly diagnosed CLL. Standardized and systems-based approaches are likely to increase compliance with skin cancer screening guidelines in patients with CLL.

AB - Purpose: Assess compliance with skin cancer screening guidelines in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia (CLL) and evaluate the clinical utility of such screening. Methods: We identified patients diagnosed at Mayo Clinic with CLL between January 1, 2004, and June 1, 2012, who resided within 30 miles of Mayo Clinic. We evaluated adherence to skin cancer screening and identified the prevalence of skin malignancies during follow-up. Medical records were reviewed to document skin cancer screening and diagnosis of a skin malignancy. Results: Collectively, 113 individuals who met criteria were diagnosed with CLL during the study interval. Forty-one patients (36%) had a whole body skin examination by either a dermatologist or primary care provider documented within 6 months of diagnosis; of these; nine (8% of overall cohort; 22% of examined patients) had a skin malignancy identified. Fifteen additional skin malignancies were diagnosed during follow-up. There were a total of 24 skin malignancies (21% of cohort) diagnosed, including basal cell carcinoma (n = 10), squamous cell carcinoma (n = 11), sebaceous carcinomas (n = 2), and melanoma (n = 1). Conclusion: We documented a low compliance with guidelines to screen for skin malignancy in a community-dwelling cohort of patients with newly diagnosed CLL. Standardized and systems-based approaches are likely to increase compliance with skin cancer screening guidelines in patients with CLL.

UR - http://www.scopus.com/inward/record.url?scp=84899899071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899899071&partnerID=8YFLogxK

U2 - 10.1200/JOP.2013.000921

DO - 10.1200/JOP.2013.000921

M3 - Article

C2 - 23981385

AN - SCOPUS:84899899071

VL - 10

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 1

ER -